Crinetics Pharmaceuticals, Inc. Impairment of Long-Lived Assets Held-for-use
Crinetics Pharmaceuticals, Inc. (CRNX) reported Impairment of Long-Lived Assets Held-for-use of $0 for the 12-month period ending 2024-12-31, per its 10-K filed 2025-02-27.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:ImpairmentOfLongLivedAssetsHeldForUse · last filed 2025-02-27
- Crinetics Pharmaceuticals, Inc. impairment of long-lived assets held-for-use for fiscal 2024 was $0.00.
- Crinetics Pharmaceuticals, Inc. impairment of long-lived assets held-for-use for fiscal 2023 was $0.00.
- Crinetics Pharmaceuticals, Inc. impairment of long-lived assets held-for-use for fiscal 2022 was $0.00.
- Crinetics Pharmaceuticals, Inc. impairment of long-lived assets held-for-use for fiscal 2021 was $0.00.
| Period end | Impairment of Long-Lived Assets Held-for-use 12 month |
|---|---|
| 2024-12-31 | $0.00 10-K · filed 2025-02-27 |
| 2023-12-31 | $0.00 10-K · filed 2025-02-27 |
| 2022-12-31 | $0.00 10-K · filed 2025-02-27 |
| 2021-12-31 | $0.00 10-K · filed 2024-02-28 |
| 2020-12-31 | $0.00 10-K · filed 2023-02-28 |
| 2019-12-31 | $0.00 10-K · filed 2022-03-30 |
| 2018-12-31 | $0.00 10-K · filed 2021-03-30 |
| 2017-12-31 | $0.00 10-K · filed 2020-03-09 |